CAR-T therapy: pioneering a new era in the treatment of autoimmune diseases

CAR-T therapy: pioneering a new era in the treatment of autoimmune diseases

CAR-T therapy, an innovative immunotherapeutic approach, genetically modifies T cells to express CARs, enabling targeted destruction of specific antigen-expressing cells. Initially developed for oncology, CAR-T therapy has shown significant potential in treating autoimmune diseases. By targeting CD1...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuanhao Wu, Luyao Han, Yu Wang, Mengjiao Gu, Yunuo Wang, Jingyue Gao, Hanjing Huang, Chen Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Immunology
Subjects:	chimeric antigen receptor T-cell therapy CAR (chimeric antigen receptor) SLE - systemic lupus erythematosus autoimmune diseases adverse (side) effects
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1625166/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CAR-T: from bench to bedside
by: M. О. Popova, et al.
Published: (2024-09-01)

Study of the suppression of a tumor growth expressing a carcinoembryonic antigen with a new high-tech drug carplasmin (CAR-T therapy) in Balb/c nude mice
by: V. K. Bozhenko, et al.
Published: (2023-04-01)

Unleashing the power of CAR-M therapy in solid tumors: a comprehensive review
by: Ahsen Morva, et al.
Published: (2025-06-01)

Efficacy and safety of CD19 combined with CD22 or CD20 chimeric antigen receptor T-cell therapy for hematological malignancies
by: Xiaoshuang Yuan, et al.
Published: (2025-05-01)

Discordant CAR-T cell signaling: implications of divergence from physiological T cell activation
by: Pablo Gonzalez-Garcia, et al.
Published: (2025-07-01)

The use of T-cells with chimeric antigen receptor (CAR-T) in combination with chemotherapy and radiotherapy for the treatment of solid tumors
by: M. R. Khaliulin, et al.
Published: (2024-04-01)

Does a natural killer need a CAR?
by: Kangbo Wang, et al.
Published: (2025-06-01)

Co-expression of a truncated TGFβ receptor II in c-Met CAR T cells enhances antitumor activity against lung adenocarcinoma
by: Chao Su, et al.
Published: (2025-08-01)

Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
by: Jing Ma, et al.
Published: (2025-07-01)

Diverse potential of chimeric antigen receptor‐engineered cell therapy: Beyond cancer
by: Lvying Wu, et al.
Published: (2025-04-01)

Can chimeric antigen receptors – based therapy bring a gleam of hope for thyroid-associated ophthalmopathy and other autoimmune diseases?
by: Zhou Weiyi, et al.
Published: (2025-04-01)

Checkpoint antibody receptor modified ARMed CAR T circumvents the suppressive immunome in GBM
by: Danielle R. Cook, et al.
Published: (2025-07-01)

Regulatory T cell therapy in autoimmune liver disease and transplantationKeypoints
by: Maegen Fleming, et al.
Published: (2025-08-01)

GPX4 is a key ferroptosis regulator orchestrating T cells and CAR-T-cells sensitivity to ferroptosis
by: Marta Kłopotowska, et al.
Published: (2025-08-01)

CD-19-directed immunotherapy resistance mechanisms of B-precursor acute lymphoblastic leukemia
by: E. V. Glukhanyuk, et al.
Published: (2019-01-01)

Dap10 co-stimulation enhances the anti-HCC efficacy of NKp30 chimeric antigen receptor T cells
by: JieYu Li, et al.
Published: (2025-07-01)

In vivo production of CAR T cell: Opportunities and challenges
by: Zhiqiang Song, et al.
Published: (2025-11-01)

Quality of life and symptom burden among hematologic malignancy patients undergoing CAR-T therapy: a cross-sectional study
by: Hongyuan Dai, et al.
Published: (2025-05-01)

Adoptitive immunotherapy with genetically engineered T lymphocytes modified to express chimeric antigen receptors
by: A. А. Pavlova, et al.
Published: (2017-04-01)

Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma
by: Lina Zhang, et al.
Published: (2021-01-01)

Inhibition of VEGF signaling prevents exhaustion and enhances anti-leukemia efficacy of CAR-T cells via Wnt/β-catenin pathway
by: Suwan Wu, et al.
Published: (2025-04-01)

Preparation of Trop2-targeted chimeric antigen receptor T cells and study of their exhaustion status in vitro
by: LIU Xiuying, et al.
Published: (2025-08-01)

Preclinical efficacy of multi-targeting mRNA-based CAR T cell therapy in resection models of glioblastoma
by: Oula K. Dagher, et al.
Published: (2025-09-01)

Biomimetic extracellular vesicles derived from chimeric antigen receptor monocytes to treat glioblastoma: An efficient and safe intranasal drug delivery nanoplatform
by: Qihong Cheng, et al.
Published: (2025-10-01)

Biomarkers for an early diagnosis of immune effector cell associated-hemophagocytic syndrome
by: Edoardo Campodonico, et al.
Published: (2025-08-01)

Robo1 CAR-NK92 and radiotherapy exert synergistic efficacy in solid tumors
by: Mengdi Wu, et al.
Published: (2025-07-01)

Effects of Mesenchymal Stem Cells on Functions of Chimeric Antigen Receptor-Expressing T Lymphocytes and Natural Killer Cells
by: Vladislav Volarevic, et al.
Published: (2025-06-01)

Revolutionizing Allogeneic Graft Tolerance Through Chimeric Antigen Receptor-T Regulatory Cells
by: Alvin Man Lung Chan, et al.
Published: (2025-07-01)

IL-7 armed binary CAR T cell strategy to augment potency against solid tumors
by: Alejandro G. Torres Chavez, et al.
Published: (2025-07-01)

Autotransplantation of T-lymphocytes as a tool for antigen-specific immunotherapy of oncological diseases
by: A. Yu. Lupatov, et al.
Published: (2018-09-01)

Dose-dependent impact of tixagevimab–cilgavimab as primary prevention against SARS-CoV-2 in immunocompromised individuals
by: Daniela Dluzynski, et al.
Published: (2025-05-01)

Breaking boundaries in ankylosing spondylitis: how innovative cell therapies reshape immunity, drive cutting-edge advances, and face future challenges
by: Minxia Ke, et al.
Published: (2025-07-01)

Recent advances of chimeric antigen receptor T‐cell therapy for acute myeloid leukemia
by: Yang Liu, et al.
Published: (2025-05-01)

Extramedullary relapse of acute lymphoblastic leukemia treated with a CAR-T cell therapy bridge to unrelated cord blood transplantation: a case report and review of the literature
by: Huibo Li, et al.
Published: (2025-08-01)

Therapeutic landscape of ovarian cancer: recent advances and emerging therapies
by: Ling Wang, et al.
Published: (2025-08-01)

A bibliometric analysis of challenges and advancements in the integrated application of nanoparticles and chimeric antigen receptor T cell therapy
by: Yang Gao, et al.
Published: (2025-12-01)

Atrial fibrillation is associated with increased in-hospitality mortality during Chimeric Antigen Receptor T-cell therapy hospitalizations: a retrospective cohort study in the United States
by: Nischit Baral, et al.
Published: (2025-07-01)

Pathogenesis of Autoimmunity/Systemic Lupus Erythematosus (SLE)
by: Shunichi Shiozawa
Published: (2025-07-01)

Genome-Editing and Biomedical Cell Products: Current State, Safety and Efficacy
by: A. A. Goryaev, et al.
Published: (2018-09-01)

Gastroparesis and Systemic Lupus Erythematosus: A Propensity Score‐Matched Study of US National Database Analysis
by: Noppachai Siranart, et al.
Published: (2025-07-01)